Insight A Conversation with WIT’s ITC Practice Chair: Examining 2024 Trends in Section 337 Investigations
Insights Home Insights Featured Content Q&As A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead. Case Study- Technology Case Study: Payment Systems Expert Needed for Trade Secret Dispute Between Technology Companies In a federal trade secret dispute, a payment technology company alleged that former senior executives stole trade secrets and proprietary information to establish a competing payment platform. Report WIT Hatch-Waxman Report: Judge Michael Shipp Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings. Blog Expert Qualifications Under Revised FRE 702: A Look at Recent Cases The 2023 amendment to Federal Rule of Evidence (FRE) 702 has introduced stricter standards for expert testimony, challenging litigators to adapt to the evolving requirements. Let’s take a look at five recent cases to see how courts are putting these requirements into practice—insights that will prove particularly valuable for litigators planning their expert strategy. Blog An Expert’s Look Inside the ITC’s NEXT Advocates Program To better understand the program and its benefits, we sat down with Daniel Pittman, an engineering expert and educator, who participated in this year’s event. Read what he had to say about his experience. Insights & News All Industries Automotive Financial Technology Gaming Healthcare Technology Pharmaceutical Wireless Communications Medical Devices All Trends 5G / 6G Banking Crisis COVID-19 Cryptocurrency Drug and Vaccine Development Election Law and Voting Rights Electric Vehicles FDA-Regulated Drugs and Devices Mobile Gaming Payment Systems Virtual Reality Wearable Devices All Insight Types Archive Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Q&As Report Video Search January 13, 2025 — Q&As A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead. December 18, 2024 — Report WIT Hatch-Waxman Report: Judge Michael Shipp Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings. October 23, 2024 — Blog Life Sciences Roundup: Top Insights from Q2 – Q3 Life sciences companies face mounting litigation over patents, products, and pricing practices. Successfully navigating these matters requires expertise from qualified experts and an expert agency focused on arising litigation trends. Check out our insights. June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings. June 12, 2024 — Report WIT Hatch-Waxman Report: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings. March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue. December 19, 2023 — Blog Maximizing the Impact of Expert Witnesses in Legal Proceedings Whether it's a business-savvy c-suite executive, highly-credentialed academic, knowledgeable industry insider, or technical specialist, experts can make all the difference in achieving a favorable outcome in a case. August 1, 2023 — In the News Rough Waters Ahead: Proposed Antitrust Guidelines Spell Trouble for Big Tech, Big Pharma, and More As the FTC and DOJ attempt to slow anticompetitive practices in the tech space, life sciences sector, and more, how will these regulators' latest proposal affect M&As among major industry players if it comes to pass? July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process? Load More Loading...
Q&As A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead.
Case Study- Technology Case Study: Payment Systems Expert Needed for Trade Secret Dispute Between Technology Companies In a federal trade secret dispute, a payment technology company alleged that former senior executives stole trade secrets and proprietary information to establish a competing payment platform.
Report WIT Hatch-Waxman Report: Judge Michael Shipp Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings.
Blog Expert Qualifications Under Revised FRE 702: A Look at Recent Cases The 2023 amendment to Federal Rule of Evidence (FRE) 702 has introduced stricter standards for expert testimony, challenging litigators to adapt to the evolving requirements. Let’s take a look at five recent cases to see how courts are putting these requirements into practice—insights that will prove particularly valuable for litigators planning their expert strategy.
Blog An Expert’s Look Inside the ITC’s NEXT Advocates Program To better understand the program and its benefits, we sat down with Daniel Pittman, an engineering expert and educator, who participated in this year’s event. Read what he had to say about his experience.
January 13, 2025 — Q&As A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead.
December 18, 2024 — Report WIT Hatch-Waxman Report: Judge Michael Shipp Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings.
October 23, 2024 — Blog Life Sciences Roundup: Top Insights from Q2 – Q3 Life sciences companies face mounting litigation over patents, products, and pricing practices. Successfully navigating these matters requires expertise from qualified experts and an expert agency focused on arising litigation trends. Check out our insights.
June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.
June 12, 2024 — Report WIT Hatch-Waxman Report: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings.
March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue.
December 19, 2023 — Blog Maximizing the Impact of Expert Witnesses in Legal Proceedings Whether it's a business-savvy c-suite executive, highly-credentialed academic, knowledgeable industry insider, or technical specialist, experts can make all the difference in achieving a favorable outcome in a case.
August 1, 2023 — In the News Rough Waters Ahead: Proposed Antitrust Guidelines Spell Trouble for Big Tech, Big Pharma, and More As the FTC and DOJ attempt to slow anticompetitive practices in the tech space, life sciences sector, and more, how will these regulators' latest proposal affect M&As among major industry players if it comes to pass?
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process?
